Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Evommune’s Dupixent-like phase 2 eczema data drive 75% stock rally

Evommune’s Dupixent-like phase 2 eczema data drive 75% stock rally

  • February 10, 2026

Evommune has aced its first major test as a public company, reporting phase 2a eczema data that caused its share price to jump 75% in premarket trading.

Leave A Comment

Fields (*) Mark are Required